Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa Community Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa DGN Gate 14 October، 2023 London, United Kingdom — Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces an exclusive license... Read More Read more about Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa
